Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.

@article{Mavrogeni2016CardiovascularMR,
  title={Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.},
  author={Sophie I Mavrogeni and George D Kitas and Theodoros Dimitroulas and Petros P. Sfikakis and Philip Seo and Sherine E. Gabriel and Amit R. Patel and Luna Gargani and Stefano Bombardieri and Marco Matucci-Cerinic and Massimo Lombardi and Alessia Pepe and Anthony H. Aletras and Genovefa D. Kolovou and Tomasz Miszalski and Piet L. C. M. van Riel and A Semb and Miguel A Gonz{\'a}lez-Gay and Patrick H Dessein and George A Karpouzas and Valentina O Puntmann and Eike Nagel and Konstantinos Bratis and Georgia Karabela and Efthymios Stavropoulos and Gikas E Katsifis and Loukia Koutsogeorgopoulou and Albert C. van Rossum and Frank E. Rademakers and Gerald M. Pohost and Joao A. C. Lima},
  journal={International journal of cardiology},
  year={2016},
  volume={217},
  pages={135-48}
}
Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed… CONTINUE READING